Moneycontrol PRO

you are here: HomeNewsBusinessEarningsBiocon Q4 EBITDA likely to go up 11% to Rs 143.4 cr

SHOW NAMES

Trending Topics

business

Biocon Q4 EBITDA likely to go up 11% to Rs 143.4 cr

Pharmaceutical firm Biocon is expected to report a growth of 2% quarter-on-quarter in its profit after tax of Rs 86.2 crore for the fourth quarter of FY12, according to CNBC-TV18 poll. The company had reported PAT of Rs 84.8 crore in the previous quarter.

first published: Apr 26, 2012 10:25 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347